Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
104.33
+0.51 (0.49%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5,0834,1003,7663,3491,4243,042
Upgrade
Market Cap Growth
8.88%8.88%12.44%135.22%-53.20%-20.03%
Upgrade
Enterprise Value
4,9603,9653,5353,2161,3592,888
Upgrade
Last Close Price
104.2384.6179.5977.1337.7881.47
Upgrade
PS Ratio
12.9510.6313.9266.94--
Upgrade
PB Ratio
88.9771.9219.7230.5791.1026.74
Upgrade
P/TBV Ratio
--29.9784.6191.1026.74
Upgrade
EV/Sales Ratio
12.8610.2813.0664.28--
Upgrade
Debt / Equity Ratio
3.383.380.980.863.180.44
Upgrade
Asset Turnover
0.670.670.590.24--
Upgrade
Inventory Turnover
2.162.162.68---
Upgrade
Quick Ratio
1.991.993.462.473.757.85
Upgrade
Current Ratio
2.112.113.632.543.757.85
Upgrade
Return on Equity (ROE)
-231.63%-231.63%-159.21%-298.97%-201.51%-70.36%
Upgrade
Return on Assets (ROA)
-27.28%-27.28%-24.86%-52.30%-56.91%-30.46%
Upgrade
Return on Capital (ROIC)
-50.30%-50.30%-39.31%-81.33%-68.00%-34.16%
Upgrade
Earnings Yield
-5.65%-7.00%-6.35%-5.59%-9.16%-3.38%
Upgrade
FCF Yield
-2.53%-3.14%-3.87%-3.50%-7.62%-2.58%
Upgrade
Buyback Yield / Dilution
-5.48%-5.48%-11.73%-8.07%-1.11%-9.37%
Upgrade
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q